Literature DB >> 27889901

A novel approach to screening for familial hypercholesterolemia in a large public venue.

Megan Campbell1, Jessa Humanki1, Heather Zierhut2.   

Abstract

The primary aim of this study was to test the feasibility of a public health screening program to identify individuals at high risk of familial hypercholesterolemia through a novel screening approach at a large public venue. A finger-prick, non-fasting lipid panel was obtained, and a survey which consisted of 44 open- and close-ended questions divided into four sections: medical and family history of FH, opinions of cascade genetic testing, patient activation, and demographics was completed. A total of 971 participants met criteria and completed a cholesterol screen. In total, five individuals met either the Simon Broome Register or the Dutch Lipid Clinic Network criteria for possible familial hypercholesterolemia. Participants were generally positive towards genetic testing, and the vast majority listed they had no barriers to communication of genetic testing information to family members. However, the most common barrier listed was lack of communication skills. Our results suggest that a public health screening program for FH is viable at a large public venue. We argue that further research is needed to expand this study to a fully operational screening program.

Entities:  

Keywords:  Cholesterol; Familial hypercholesterolemia; Genetic communication; Genetic information; Genetic screening; Genetic testing

Year:  2016        PMID: 27889901      PMCID: PMC5222759          DOI: 10.1007/s12687-016-0285-1

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  33 in total

1.  Lay Attitudes toward Genetic Testing for Susceptibility to Inherited Diseases.

Authors:  J S Shaw; K L Bassi
Journal:  J Health Psychol       Date:  2001-07

2.  Facilitating family communication about predictive genetic testing: probands' perceptions.

Authors:  Clara L Gaff; Veronica Collins; Tiffany Symes; Jane Halliday
Journal:  J Genet Couns       Date:  2005-04       Impact factor: 2.537

3.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

Review 4.  Cascade testing in familial hypercholesterolaemia: how should family members be contacted?

Authors:  Ainsley J Newson; Steve E Humphries
Journal:  Eur J Hum Genet       Date:  2005-04       Impact factor: 4.246

5.  Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia.

Authors:  Dalya Marks; David Wonderling; Margaret Thorogood; Helen Lambert; Steve E Humphries; H Andrew W Neil
Journal:  BMJ       Date:  2002-06-01

6.  A comparison of positive family history definitions for defining risk of future disease.

Authors:  S C Hunt; R R Williams; G K Barlow
Journal:  J Chronic Dis       Date:  1986

7.  Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK.

Authors:  Saskia C Sanderson; Jane Wardle; Martin J Jarvis; Steve E Humphries
Journal:  Prev Med       Date:  2004-09       Impact factor: 4.018

8.  Coronary artery disease in heterozygous familial hypercholesterolemia.

Authors:  K Hirobe; Y Matsuzawa; K Ishikawa; S Tarui; A Yamamoto; S Nambu; K Fujimoto
Journal:  Atherosclerosis       Date:  1982-08       Impact factor: 5.162

9.  Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.

Authors:  Amit V Khera; Hong-Hee Won; Gina M Peloso; Kim S Lawson; Traci M Bartz; Xuan Deng; Elisabeth M van Leeuwen; Pradeep Natarajan; Connor A Emdin; Alexander G Bick; Alanna C Morrison; Jennifer A Brody; Namrata Gupta; Akihiro Nomura; Thorsten Kessler; Stefano Duga; Joshua C Bis; Cornelia M van Duijn; L Adrienne Cupples; Bruce Psaty; Daniel J Rader; John Danesh; Heribert Schunkert; Ruth McPherson; Martin Farrall; Hugh Watkins; Eric Lander; James G Wilson; Adolfo Correa; Eric Boerwinkle; Piera Angelica Merlini; Diego Ardissino; Danish Saleheen; Stacey Gabriel; Sekar Kathiresan
Journal:  J Am Coll Cardiol       Date:  2016-04-03       Impact factor: 24.094

10.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.

Authors:  Børge G Nordestgaard; M John Chapman; Steve E Humphries; Henry N Ginsberg; Luis Masana; Olivier S Descamps; Olov Wiklund; Robert A Hegele; Frederick J Raal; Joep C Defesche; Albert Wiegman; Raul D Santos; Gerald F Watts; Klaus G Parhofer; G Kees Hovingh; Petri T Kovanen; Catherine Boileau; Maurizio Averna; Jan Borén; Eric Bruckert; Alberico L Catapano; Jan Albert Kuivenhoven; Päivi Pajukanta; Kausik Ray; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen
Journal:  Eur Heart J       Date:  2013-08-15       Impact factor: 29.983

View more
  5 in total

Review 1.  Barriers and facilitators for cascade testing in genetic conditions: a systematic review.

Authors:  Swetha Srinivasan; Nae Yeon Won; W David Dotson; Sarah T Wright; Megan C Roberts
Journal:  Eur J Hum Genet       Date:  2020-09-18       Impact factor: 4.246

2.  Q192R polymorphism in the PON1 gene and familial hypercholesterolemia in a Saudi population.

Authors:  Khalid Khalaf Alharbi; May Salem Alnbaheen; Fawiziah Khalaf Alharbi; Rana M Hasanato; Imran Ali Khan
Journal:  Ann Saudi Med       Date:  2017 Nov-Dec       Impact factor: 1.526

3.  Understanding Implementation Challenges to Genetic Testing for Familial Hypercholesterolemia in the United States.

Authors:  Rachele M Hendricks-Sturrup; Christine Y Lu
Journal:  J Pers Med       Date:  2019-02-01

Review 4.  Barriers and Facilitators to Genetic Testing for Familial Hypercholesterolemia in the United States: A Review.

Authors:  Rachele M Hendricks-Sturrup; Kathleen M Mazor; Amy C Sturm; Christine Y Lu
Journal:  J Pers Med       Date:  2019-07-01

5.  Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication.

Authors:  Gemme Campbell-Salome; Nicole L Walters; Ilene G Ladd; Amanda Sheldon; Catherine Davis Ahmed; Andrew Brangan; Megan N McMinn; Alanna K Rahm; Marci L B Schwartz; Eric Tricou; Carla L Fisher; Amy C Sturm
Journal:  Transl Behav Med       Date:  2022-07-18       Impact factor: 3.626

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.